Obstructive cholestasis alters intestinal transit in mice

Role of opioid system

Kamyar Ghaffari, Shahab Tour Savadkuhi, Hooman Honar, Kiarash Riazi, Hamed Shafaroodi, Leila Moezi, Mohammad Ebrahimkhani, Mohammad Saeid Radjabzadeh Tahmasebi, Ahmad Reza Dehpour

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Acute cholestasis is associated with increased activity of the endogenous opioid system. It is also known that opioid receptor agonists like morphine decrease the intestinal transit. The purpose of the present study was to investigate the effect of cholestasis on the small intestine transit and the possible involvement of opioid system in this phenomenon in mice. Cholestasis was induced by bile duct-ligation and intestinal transit was measured with charcoal meal and calculation of percent of transit through small intestine. The effect of chronic administration of naltrexone and acute pretreatment with morphine on intestinal transit was evaluated in bile duct-ligated (BDL) as well as unoperated (CTL) and sham-operated (SHAM) animals. The plasma alkaline phosphatase and alanine aminotransferase activities were also measured. A significant decrease in small intestine transit (%transit) was observed in BDL mice compared to SHAM animals, which was prominent even after 24 h of cholestasis. Chronic pretreatment with an opioid receptor antagonist, naltrexone, (10 mg/kg, i.p for 2, 4 or 6 days) completely restored the cholestasis-induced decrease in %transit to that of control animals. Although the acute administration of morphine (2 mg/kg, s.c.) 20 min before charcoal feeding caused a significant decrease in the intestinal transit of CTL and SHAM animals, it did not decrease the %transit of BDL animals on the day 5 after operation. Our findings show that acute cholestasis is associated with a prominent decrease in small intestine transit in mice and opioid receptors maybe involved in this phenomenon.

Original languageEnglish (US)
Pages (from-to)397-406
Number of pages10
JournalLife Sciences
Volume76
Issue number4
DOIs
StatePublished - Dec 10 2004
Externally publishedYes

Fingerprint

Cholestasis
Opioid Analgesics
Animals
Ducts
Bile Ducts
Small Intestine
Morphine
Naltrexone
Charcoal
Opioid Receptors
Narcotic Antagonists
Alanine Transaminase
Alkaline Phosphatase
Ligation
Meals
Plasmas
salicylhydroxamic acid

Keywords

  • Cholestasis
  • Endogenous opioids
  • Mice
  • Small intestine transit

ASJC Scopus subject areas

  • Pharmacology

Cite this

Ghaffari, K., Savadkuhi, S. T., Honar, H., Riazi, K., Shafaroodi, H., Moezi, L., ... Dehpour, A. R. (2004). Obstructive cholestasis alters intestinal transit in mice: Role of opioid system. Life Sciences, 76(4), 397-406. https://doi.org/10.1016/j.lfs.2004.09.002

Obstructive cholestasis alters intestinal transit in mice : Role of opioid system. / Ghaffari, Kamyar; Savadkuhi, Shahab Tour; Honar, Hooman; Riazi, Kiarash; Shafaroodi, Hamed; Moezi, Leila; Ebrahimkhani, Mohammad; Tahmasebi, Mohammad Saeid Radjabzadeh; Dehpour, Ahmad Reza.

In: Life Sciences, Vol. 76, No. 4, 10.12.2004, p. 397-406.

Research output: Contribution to journalArticle

Ghaffari, K, Savadkuhi, ST, Honar, H, Riazi, K, Shafaroodi, H, Moezi, L, Ebrahimkhani, M, Tahmasebi, MSR & Dehpour, AR 2004, 'Obstructive cholestasis alters intestinal transit in mice: Role of opioid system', Life Sciences, vol. 76, no. 4, pp. 397-406. https://doi.org/10.1016/j.lfs.2004.09.002
Ghaffari K, Savadkuhi ST, Honar H, Riazi K, Shafaroodi H, Moezi L et al. Obstructive cholestasis alters intestinal transit in mice: Role of opioid system. Life Sciences. 2004 Dec 10;76(4):397-406. https://doi.org/10.1016/j.lfs.2004.09.002
Ghaffari, Kamyar ; Savadkuhi, Shahab Tour ; Honar, Hooman ; Riazi, Kiarash ; Shafaroodi, Hamed ; Moezi, Leila ; Ebrahimkhani, Mohammad ; Tahmasebi, Mohammad Saeid Radjabzadeh ; Dehpour, Ahmad Reza. / Obstructive cholestasis alters intestinal transit in mice : Role of opioid system. In: Life Sciences. 2004 ; Vol. 76, No. 4. pp. 397-406.
@article{76e593ef04d54b8382441dcc73ea3804,
title = "Obstructive cholestasis alters intestinal transit in mice: Role of opioid system",
abstract = "Acute cholestasis is associated with increased activity of the endogenous opioid system. It is also known that opioid receptor agonists like morphine decrease the intestinal transit. The purpose of the present study was to investigate the effect of cholestasis on the small intestine transit and the possible involvement of opioid system in this phenomenon in mice. Cholestasis was induced by bile duct-ligation and intestinal transit was measured with charcoal meal and calculation of percent of transit through small intestine. The effect of chronic administration of naltrexone and acute pretreatment with morphine on intestinal transit was evaluated in bile duct-ligated (BDL) as well as unoperated (CTL) and sham-operated (SHAM) animals. The plasma alkaline phosphatase and alanine aminotransferase activities were also measured. A significant decrease in small intestine transit ({\%}transit) was observed in BDL mice compared to SHAM animals, which was prominent even after 24 h of cholestasis. Chronic pretreatment with an opioid receptor antagonist, naltrexone, (10 mg/kg, i.p for 2, 4 or 6 days) completely restored the cholestasis-induced decrease in {\%}transit to that of control animals. Although the acute administration of morphine (2 mg/kg, s.c.) 20 min before charcoal feeding caused a significant decrease in the intestinal transit of CTL and SHAM animals, it did not decrease the {\%}transit of BDL animals on the day 5 after operation. Our findings show that acute cholestasis is associated with a prominent decrease in small intestine transit in mice and opioid receptors maybe involved in this phenomenon.",
keywords = "Cholestasis, Endogenous opioids, Mice, Small intestine transit",
author = "Kamyar Ghaffari and Savadkuhi, {Shahab Tour} and Hooman Honar and Kiarash Riazi and Hamed Shafaroodi and Leila Moezi and Mohammad Ebrahimkhani and Tahmasebi, {Mohammad Saeid Radjabzadeh} and Dehpour, {Ahmad Reza}",
year = "2004",
month = "12",
day = "10",
doi = "10.1016/j.lfs.2004.09.002",
language = "English (US)",
volume = "76",
pages = "397--406",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Obstructive cholestasis alters intestinal transit in mice

T2 - Role of opioid system

AU - Ghaffari, Kamyar

AU - Savadkuhi, Shahab Tour

AU - Honar, Hooman

AU - Riazi, Kiarash

AU - Shafaroodi, Hamed

AU - Moezi, Leila

AU - Ebrahimkhani, Mohammad

AU - Tahmasebi, Mohammad Saeid Radjabzadeh

AU - Dehpour, Ahmad Reza

PY - 2004/12/10

Y1 - 2004/12/10

N2 - Acute cholestasis is associated with increased activity of the endogenous opioid system. It is also known that opioid receptor agonists like morphine decrease the intestinal transit. The purpose of the present study was to investigate the effect of cholestasis on the small intestine transit and the possible involvement of opioid system in this phenomenon in mice. Cholestasis was induced by bile duct-ligation and intestinal transit was measured with charcoal meal and calculation of percent of transit through small intestine. The effect of chronic administration of naltrexone and acute pretreatment with morphine on intestinal transit was evaluated in bile duct-ligated (BDL) as well as unoperated (CTL) and sham-operated (SHAM) animals. The plasma alkaline phosphatase and alanine aminotransferase activities were also measured. A significant decrease in small intestine transit (%transit) was observed in BDL mice compared to SHAM animals, which was prominent even after 24 h of cholestasis. Chronic pretreatment with an opioid receptor antagonist, naltrexone, (10 mg/kg, i.p for 2, 4 or 6 days) completely restored the cholestasis-induced decrease in %transit to that of control animals. Although the acute administration of morphine (2 mg/kg, s.c.) 20 min before charcoal feeding caused a significant decrease in the intestinal transit of CTL and SHAM animals, it did not decrease the %transit of BDL animals on the day 5 after operation. Our findings show that acute cholestasis is associated with a prominent decrease in small intestine transit in mice and opioid receptors maybe involved in this phenomenon.

AB - Acute cholestasis is associated with increased activity of the endogenous opioid system. It is also known that opioid receptor agonists like morphine decrease the intestinal transit. The purpose of the present study was to investigate the effect of cholestasis on the small intestine transit and the possible involvement of opioid system in this phenomenon in mice. Cholestasis was induced by bile duct-ligation and intestinal transit was measured with charcoal meal and calculation of percent of transit through small intestine. The effect of chronic administration of naltrexone and acute pretreatment with morphine on intestinal transit was evaluated in bile duct-ligated (BDL) as well as unoperated (CTL) and sham-operated (SHAM) animals. The plasma alkaline phosphatase and alanine aminotransferase activities were also measured. A significant decrease in small intestine transit (%transit) was observed in BDL mice compared to SHAM animals, which was prominent even after 24 h of cholestasis. Chronic pretreatment with an opioid receptor antagonist, naltrexone, (10 mg/kg, i.p for 2, 4 or 6 days) completely restored the cholestasis-induced decrease in %transit to that of control animals. Although the acute administration of morphine (2 mg/kg, s.c.) 20 min before charcoal feeding caused a significant decrease in the intestinal transit of CTL and SHAM animals, it did not decrease the %transit of BDL animals on the day 5 after operation. Our findings show that acute cholestasis is associated with a prominent decrease in small intestine transit in mice and opioid receptors maybe involved in this phenomenon.

KW - Cholestasis

KW - Endogenous opioids

KW - Mice

KW - Small intestine transit

UR - http://www.scopus.com/inward/record.url?scp=7644226183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7644226183&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2004.09.002

DO - 10.1016/j.lfs.2004.09.002

M3 - Article

VL - 76

SP - 397

EP - 406

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 4

ER -